Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer

Journal of Clinical Pathology

Volumn 55, Issue 10, 2002, Pages 758-762

  Leeman, M F ^a   McKay, J A ^a   Murray, G I ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; TUMOR CELL; ZYMOGRAPHY;

ADULT; AGED; COLLAGENASES; COLORECTAL NEOPLASMS; CYTOPLASM; ENZYME ACTIVATION; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 13; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0036774674     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.55.10.758     Document Type: Article

References (23)

1. McLeod HL, Murray GI. Tumour markers of prognosis in colorectal cancer. Br J Cancer 1999;79:191-203.
2. Curran S, Murray GI. Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 1999;189:300-8.
3. Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000;36:1621-30.
4. Murray GI, Duncan ME, O'Neil P, el al. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996;2:461-2.
5. Zeng ZS, Huang Y, Cohen AM, et al. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol 1996;14:3133-40.
6. Adachi Y, Yamamoto H, Itoh F, et al. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 1999;45:252-8.
7. Kikuchi R, Noguchi T, Takeno S, et al. Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma. Br J Cancer 2000;83:215-18.
8. Sardinha TC, Nogueras JJ, Xiong H, et al. Membrane-type 1 matrix metalloproteinase mRNA expression in colorectal cancer. Dis Colon Rectum 2000;43:389-95.
9. Freije JMP, Diez-Itza I, Balbín M, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994;269:16766-73.
10. Knäuper V, López-Otín C, Smith B, et al. Biochemical characterisation of human collagenase-3. J Biol Chem 1996;271:1544-50.
11. Knäuper V, Will H, López-Otín C, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 1996;271:17124-31.
12. Knäuper V, Smith B, López-Otín C, et al. Activation of progelatinase b (proMMP-9) by active collagenase-3 (MMP-13). Eur J Biochem 1997;248:369-73.
13. Cowell S, Knäuper V, Stewart ML, et al. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase a, gelatinase b and collagenase 3. Biochem J 1998;331:453-8.
14. Johansson N, Airola K, Grénman R, et al. Expression of collagenase-3 (matrix metalloproteinasel 13) in squamous cell carcinomas of the head and neck. Am J Pathol 1997;151:499-508.
15. Boström PJ, Ravanti L, Reunanen N, et al. Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder. Int J Cancer 2000;88:417-23.
16. Cazorla M, Hernández L, Nadal A, et al. Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J Pathol 1998;186:144-50.
17. Etoh T, Inoue H, Yoshikawa Y, et al. Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness. Gut 2000;47:50-6.
18. Johansson N, Vaalamo M, Grénman S, et al. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol 1999;154:469-80.
19. Heppner KJ, Matrisian LM, Jensen RA, et al. Expression of most matrix metalloproteinase family members in breast cancer represents a tumour-induced host response. Am J Pathol 1996;149:273-82.
20. Airola K, Karonen T, Vaalamo M, et al. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer 1999;80:733-43.
21. Uria J, Balbin M, López JM, et al. Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am J Pathol 1998;153:91-101.
22. McLeod HL, Murray GI, Mollison J, et al. Selection of markers to predict tumour response or survival: description of a novel approach. Eur J Cancer 1999;15:1650-2.
23. McKay JA, Lloret C, Murray GI, et al. Application of the enrichment approach to identify putative markers of response to 5-fluorouracil therapy in advanced colorectal carcinomas. lnt J Oncol 2000;17:153-8.